Yolanda Barbachano has been appointed as Head of Statistics for Quanticate.
Massive Bio announced the addition of two executives to its C-suite: Özgür “Oz” Huner as their first Chief Product Officer, and Erkan Terzi has been promoted to Chief Marketing Officer.
Encapsia announced the appointment of Francis Destin as its new Chief Operating Officer.
Dawn Sauro has been named as Elligo’s Chief Operating Officer.
Trialbee announced the addition of Kristopher Sarajian as their new Vice President of Marketing.
Greenphire has appointed Owen Newman as the Chief Financial Officer.
Emmes appointed Matt Honan as Vice President and Head of Corporate Development.
NNIT has received its recertification as a Veeva Premiere Services Partner – Development Cloud.
Suvoda LLC surpassed 1,000 clinical trials in 2022 as study deployments surged nearly 20%.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.